Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β

European Journal of Neuroscience

Volumn 40, Issue 2, 2014, Pages 2442-2453

  Maurin, Hervé ^a   Lechat, Benoit ^a   Borghgraef, Peter ^a   Devijver, Herman ^a   Jaworski, Tomasz ^b   Van Leuven, Fred ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Body temperature; Neurodegeneration; Precocious death; Tauopathy

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN; GLYCOGEN SYNTHASE KINASE 3; MAPT PROTEIN, HUMAN; PROTEIN SUBUNIT;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOREBRAIN; HYPOTHERMIA; MALE; MORTALITY; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TAUOPATHY; ANIMAL; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SUBUNIT; TOXICITY;

ANIMALS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYPOTHERMIA; MICE; NEURONS; PHOSPHORYLATION; PROSENCEPHALON; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; TAU PROTEINS; TAUOPATHIES;

EID: 84904672479     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12595     Document Type: Article

References (41)

1. Arendt, T. (2004) Neurodegeneration and plasticity. Int. J. Dev. Neurosci., 22, 507-514.
2. Arendt, T. & Bullmann, T. (2013) Neuronal plasticity in hibernation and the proposed role of the microtubule-associated protein tau as a 'master switch' regulating synaptic gain in neuronal networks. Am. J. Physiol.-Reg. I., 305, R478-R489.
3. Arendt, T., Stieler, J., Strijkstra, A.M., Hut, R.A., Rüdiger, J., Van der Zee, E.A., Harkany, T., Holzer, M. & Härtig, W. (2003) Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J. Neurosci., 23, 6972-6981.
4. Borghgraef, P., Menuet, C., Theunis, C., Louis, J.V., Devijver, H., Maurin, H., Smet-Nocca, C., Lippens, G., Hilaire, G., Gijsen, H., Moechars, D. & Van Leuven, F. (2013) Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L Mice. PLoS ONE, 8, e84442.
5. Braak, H. & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82, 239-259.
6. Bretteville, A., Marcouiller, F., Julien, C., El Khoury, N.B., Petry, F.R., Poitras, I., Mouginot, D., Lévesque, G., Hébert, S.S. & Planel, E. (2012) Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci. Rep., 2, 480.
7. Crespo-Biel, N., Theunis, C. & Van Leuven, F. (2012) Protein Tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease. Int. J. Alzheimers Dis., 2012, 1-13.
8. Crespo-Biel, N., Theunis, C., Borghraef, P., Lechat, B., Devijver, H., Maurin, H. & Van Leuven, F. (2014) Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301LxGSK3b mice by delaying brainstem tauopathy. Neurobiol. Dis., doi: 10.1016/j.nbd.2014.03.016. [Epub ahead of print].
9. Dewachter, I., Reversé, D., Caluwaerts, N., Ris, L., Kuipéri, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., Moechars, D., Mercken, M., Godaux, E. & Van Leuven, F. (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci., 22, 3445-3453.
10. Dutschmann, M., Menuet, C., Stettner, G.M., Gestreau, C., Borghgraef, P., Devijver, H., Gielis, L., Hilaire, G. & Van Leuven, F. (2010) Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J. Neurosci., 30, 1810-1821.
11. Hanger, D.P., Seereeram, A. & Noble, W. (2009) Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev. Neurother., 9, 1647-1666.
12. Härtig, W., Stieler, J., Boerema, A.S., Wolf, J., Schmidt, U., Weissfuss, J., Bullmann, T., Strijkstra, A.M. & Arendt, T. (2007) Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur. J. Neurosci., 25, 69-80.
13. Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T. & Imahori, K. (1993) Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett., 325, 167-172.
14. Jaworski, T., Dewachter, I., Seymour, C.M., Borghgraef, P., Devijver, H., Kügler, S. & Van Leuven, F. (2010) Alzheimer's disease: old problem, new views from transgenic and viral models. Biochim. Biophys. Acta, 1802, 808-818.
15. Jaworski, T., Dewachter, I., Lechat, B., Gees, M., Kremer, A., Demedts, D., Borghgraef, P., Devijver, H., Kügler, S., Patel, S., Woodgett, J.R. & Van Leuven, F. (2011) GSK-3α/β kinases and amyloid production in vivo. Nature, 480, E4-E5.
16. Kremer, A., Louis, J.V., Jaworski, T. & Van Leuven, F. (2011a) GSK3 and Alzheimer's disease: facts and fiction. Front. Mol. Neurosci., 4, 17.
17. Kremer, A., Maurin, H., Demedts, D., Devijver, H., Borghgraef, P. & Van Leuven, F. (2011b) Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice. J. Neurosci., 31, 18036-18047.
18. Lippens, G., Amniai, L., Wieruszeski, J.-M., Sillen, A., Leroy, A. & Landrieu, I. (2012) Towards understanding the phosphorylation code of tau. Biochem. Soc. T., 40, 698-703.
19. Louis, J.V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Longin, S., Zwaenepoel, K., Pijnenborg, R., Landrieu, I., Lippens, G., Ledermann, B., Götz, J., Van Leuven, F., Goris, J. & Janssens, V. (2011) Mice lacking phosphatase PP2A subunit PR61/B′delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc. Natl. Acad. Sci. USA, 108, 6957-6962.
20. Martin, L., Latypova, X., Wilson, C.M., Magnaudeix, A., Perrin, M.-L. & Terro, F. (2013) Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A. Ageing Res. Rev., 12, 39-49.
21. Maurin, H., Seymour, C.M., Lechat, B., Borghgraef, P., Devijver, H., Jaworski, T., Schmidt, M.V., Kuegler, S. & Van Leuven, F. (2013a) Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare. PLoS ONE, 8, e63589.
22. Maurin, H., Lechat, B., Dewachter, I., Ris, L., Louis, J.V., Borghgraef, P., Devijver, H., Jaworski, T. & Van Leuven, F. (2013b) Neurological characterization of mice deficient in GSK3alpha highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase. Mol. Brain, 6, 27.
23. Menuet, C., Borghgraef, P., Matarazzo, V., Gielis, L., Lajard, A.-M., Voituron, N., Gestreau, C., Dutschmann, M., Van Leuven, F. & Hilaire, G. (2011a) Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease. Resp. Physiol. Neurobi., 178, 290-303.
24. Menuet, C., Kourdougli, N., Hilaire, G. & Voituron, N. (2011b) Differences in serotoninergic metabolism possibly contribute to differences in breathing phenotype of FVB/N and C57BL/6J mice. J. Appl. Physiol., 110, 1572-1581.
25. Menuet, C., Borghgraef, P., Voituron, N., Gestreau, C., Gielis, L., Devijver, H., Dutschmann, M., Van Leuven, F. & Hilaire, G. (2012) Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseases. Neurobiol. Dis., 46, 234-243.
26. Morrison, S.F. & Nakamura, K. (2011) Central neural pathways for thermoregulation. Front. Biosci., 16, 74-104.
27. Nelson, P.T., Alafuzoff, I., Bigio, E.H., Bouras, C., Braak, H., Cairns, N.J., Castellani, R.J., Crain, B.J., Davies, P., Del Tredici, K., Duyckaerts, C., Frosch, M.P., Haroutunian, V., Hof, P.R., Hulette, C.M., Hyman, B.T., Iwatsubo, T., Jellinger, K.A., Jicha, G.A., Kövari, E., Kukull, W.A., Leverenz, J.B., Love, S., Mackenzie, I.R., Mann, D.M., Masliah, E., McKee, A.C., Montine, T.J., Morris, J.C., Schneider, J.A., Sonnen, J.A., Thal, D.R., Trojanowski, J.Q., Troncoso, J.C., Wisniewski, T., Woltjer, R.L. & Beach, T.G. (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropath. Exp. Neur., 71, 362-381.
28. Planel, E., Yasutake, K., Fujita, S.C. & Ishiguro, K. (2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3β and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem., 276, 34298-34306.
29. Planel, E., Richter, K.E.G., Nolan, C.E., Finley, J.E., Liu, L., Wen, Y., Krishnamurthy, P., Herman, M., Wang, L., Schachter, J.B., Nelson, R.B., Lau, L.-F. & Duff, K.E. (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J. Neurosci., 27, 3090-3097.
30. Pooler, A.M. & Hanger, D.P. (2010) Functional implications of the association of tau with the plasma membrane. Biochem. Soc. T., 38, 1012-1015.
31. Ray, M.A., Johnston, N.A., Verhulst, S., Trammell, R.A. & Toth, L.A. (2010) Identification of markers for imminent death in mice used in longevity and aging research. J. Am. Assoc. Lab. Anim., 49, 282-288.
32. Rosenberg, K.J., Ross, J.L., Feinstein, H.E., Feinstein, S.C. & Israelachvili, J. (2008) Complementary dimerization of microtubule-associated tau protein: implications for microtubule bundling and tau-mediated pathogenesis. Proc. Natl. Acad. Sci. USA, 105, 7445-7450.
33. Run, X., Liang, Z., Zhang, L., Iqbal, K., Grundke-Iqbal, I. & Gong, C.-X. (2009) Anesthesia induces phosphorylation of tau. J. Alzheimers Dis., 16, 619-626.
34. Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., Van Lint, J., Vandenheede, J., Moechars, D., Loos, R. & Van Leuven, F. (2000) Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J. Biol. Chem., 275, 41340-41349.
35. Stieler, J.T., Bullmann, T., Kohl, F., Tøien, Ø., Brückner, M.K., Härtig, W., Barnes, B.M. & Arendt, T. (2011) The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS ONE, 6, e14530.
36. Su, B., Wang, X., Drew, K.L., Perry, G., Smith, M.A. & Zhu, X. (2008) Physiological regulation of tau phosphorylation during hibernation. J. Neurochem., 105, 2098-2108.
37. Tan, W., Cao, X., Wang, J., Lv, H., Wu, B. & Ma, H. (2010) Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats. Eur. J. Anaesth., 27, 835-841.
38. Terwel, D., Lasrado, R., Snauwaert, J., Vandeweert, E., Van Haesendonck, C., Borghgraef, P. & Van Leuven, F. (2005) Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem., 280, 3963-3973.
39. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H. & Van Leuven, F. (2008) Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol., 172, 786-798.
40. Theunis, C., Crespo-biel, N., Gafner, V., Pihlgren, M., Lopez-Deber, M.P., Reis, P., Hickman, D.T., Adolfsson, O., Chuard, N., Ndao, D.M., Borghgraef, P., Devijver, H., Van Leuven, F., Pfeifer, A. & Muhs, A. (2013) Efficacy and safety of a liposome-based vaccine against protein tau, assessed in Tau.P301L mice that model tauopathy. PLoS ONE, 8, e72301.
41. Yanagisawa, M., Planel, E., Ishiguro, K. & Fujita, S.C. (1999) Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett., 461, 329-333.